Abbott Laboratories (ABT) Work In Process (2009 - 2026)

Abbott Laboratories has disclosed Work In Process across 18 years of filings, most recently posting $994.0 million for Q1 2026.

• Work In Process for Q1 2026 came in at $994.0 million, up 11.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $994.0 million (up 11.69% YoY), and the FY2025 annual result was $904.0 million, up 7.62% from the prior year.
• Work In Process came in at $994.0 million for Q1 2026 at Abbott Laboratories, up from $904.0 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $994.0 million in Q1 2026 to a low of $680.0 million in Q4 2022.
• The 5-year median for Work In Process is $877.0 million (2024), against an average of $843.8 million.
• Across the five-year window, Work In Process dropped 10.8% in 2022 and increased 22.31% in 2023, its largest moves.
• Abbott Laboratories' Work In Process stood at $680.0 million in 2022, then grew by 18.68% to $807.0 million in 2023, then grew by 4.09% to $840.0 million in 2024, then grew by 7.62% to $904.0 million in 2025, then gained by 9.96% to $994.0 million in 2026.
• The last three Work In Process figures came in at $994.0 million (Q1 2026), $904.0 million (Q4 2025), and $961.0 million (Q3 2025), per Business Quant data.